Aura Biosciences
AURA
78 hedge funds and large institutions have $307M invested in Aura Biosciences in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 7 closing their positions.
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
74% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 19
8% more funds holding
Funds holding: 72 → 78 (+6)
4.13% more ownership
Funds ownership: 75.37% → 79.5% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more call options, than puts
Call options by funds: $12K | Put options by funds: $12K
7% less capital invested
Capital invested by funds: $329M → $307M (-$21.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$7.07M |
| 2 |
BlackRock
New York
|
+$2.87M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.99M |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$1.84M |
| 5 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$1.28M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.76M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$672K |
| 3 |
Morgan Stanley
New York
|
-$652K |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$532K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$517K |
AURA Hedge Fund Activity: Q1 2024 in Review
78 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q1 2024, worth a combined $307M — down 6.5% from $329M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AURA positions and 7 closed out — a net gain of 6 holders — while 33 added to existing stakes and 19 trimmed.
The largest buyer was Franklin Resources, adding an estimated $7.07M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $1.76M sold.
- 78 institutional investors held Aura Biosciences (AURA) as of Q1 2024, up from 72 in Q4 2023.
- Funds reported $307M of Aura Biosciences stock for Q1 2024, down 6.5% quarter-over-quarter.
- 13 funds opened new Aura Biosciences positions in Q1 2024 and 7 closed out, a net change of +6 holders.
- The largest Aura Biosciences buyer in Q1 2024 was Franklin Resources, an estimated $7.07M added.
- The largest Aura Biosciences seller in Q1 2024 was Monashee Investment Management, an estimated $1.76M sold.
Based on aggregated 13F filings for Q1 2024.